News
Select Category
| All Entries | New Antibodies | Research News | About antibodies-online.com |
Modulation of Gene Expression via Disruption of NF-kappa-B Signaling by a Bacterial Small Molecule
Areas: Bacteria, Immunology
The bacterial N-3-oxo-dodecanoyl homoserine lactone (C12) selectively impairs the regulation of NF-κ-B functions in activated mammalian cells, according to the data of a research group from The Scripps Research Institute (USA). The nuclear transcription factor NF-κ-B is indispensable for the defence of the body against invading microbial pathogens. Activation of NF-κ-B controls the innate immune response, thus eradicating harmful pathogens.
If NF-κ-B is impaired by C12, NF-κ-B-controlled genes that encode inflammatory cytokines and other immune regulators are suppressed. This seems to be a strategy of C12-producing pathogens like Pseudomonas aeruginosa to decrease the effect of the innate immune system on them. By this mechanism they can establish and retain long-lasting local infections in mammals, like cystic fibrosis.
Related antibodies on antibodies-online.com:
Pseudomonas aeruginosaAntibodies for the research area bacteria: »Show antibodies
Antibodies for the research area immunology: »Show antibodies
-

09.02.2012 Conference: ICNBS Egypt 2012 -

02.02.2012 Heidelberg Forum for Young Life Scientists -

12.01.2012 BioChina International 2012 -

12.01.2012 Biomanufacturing Summit 2012 -

06.01.2012 2nd Annual International Conference on Advances in Biotechnology (BIOTECH 2012) -

16.12.2011 Conference: 2nd annual Clinical Trials in Oncology -

16.12.2011 Conference: 5th Annual CEE & CIS Clinical Trials Forum -

23.11.2011 BioPharma Asia Convention 2012 -

28.10.2011 2nd World Congress on Analytical and Bioanalytical Techniques -

27.10.2011 2nd Annual Clinical Trials in Oncology Conference -

27.10.2011 Conference: Data Management in Clinical Trials -

19.10.2011 International Conference on Ovarian Cancer Screening 2011 -

19.10.2011 Conference: Ensuring the high quality of your clinical data in an era of cost cutting -

06.10.2011 Conference: World Stem Cells & Regenerative Medicine Congress Asia 2011 -

15.09.2011 Conference: Vaccines and Biologics -

15.09.2011 BIT's 4th Annual International Congress of Antibody (ICA2012) -

30.08.2011 Biosimilars and Biobetters conference: Aligning business & science for success -

30.08.2011 Regenerative Medicine: Barriers to commercialisation online summit 2011 -

26.08.2011 World Antibody Focus 2011 -

26.08.2011 SMi’s 10th annual Clinical Trials in CNS conference -

28.07.2011 Cancer Research Global Summit -

22.07.2011 Conference: VacChina 2011 -

21.06.2011 Conference: Your gateway to the Rare Disease market in Asia -

21.06.2011 Conference: Accelerate your stem cell development to commercialization -

25.05.2011 Microscopy Conference 2011

